Jul 4th latest updates in the global new drug development field, including progress in new drug research and development, transaction information, and partnership developments.
Jul 3rd latest updates in the global new drug development field, including progress in new drug research and development, transaction information, and partnership developments.
The U.S. Food and Drug Administration (FDA) approved Rukobia on July 2, 2020, for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection.
The U.S. Food and Drug Administration (FDA) approved Dojolvi on June 30, 2020, for the treatment of long-chain fatty acid oxidation disorders (LC-FAODs) in adults and children.